Published in Infect Immun on March 01, 1981
Candida albicans-induced agglutinin and immunoglobulin E responses in mice. Infect Immun (1983) 0.93
Influence of preformed antibody on the pathogenesis of experimental Candida albicans endocarditis. Infect Immun (1983) 0.89
Protective ribosomal preparation from Shigella sonnei as a parenteral candidate vaccine. Infect Immun (1991) 0.83
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J (1956) 124.75
Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst (1959) 94.48
Preparation of RNA and ribosomes from yeast. Methods Cell Biol (1975) 5.75
The compromised host and infection. II. Deep fungal infection. J Infect Dis (1969) 4.63
Systemic fungal infections complicating renal transplantation and immunosuppressive therapy. Clinical, microbiologic, neurologic and pathologic features. Am J Med (1967) 4.08
Fungal septicemia in patients receiving parenteral hyperalimentation. N Engl J Med (1971) 3.14
UNIQUENESS OF BACTERIAL RIBOSOMES. Proc Natl Acad Sci U S A (1964) 2.67
Immunogenicity of Ribonucleic Acid Preparations Obtained from Salmonella typhimurium. Infect Immun (1970) 2.54
The assembly of ribosomes in yeast. J Biol Chem (1971) 1.99
Immunogenicity of ribosomal vaccines isolated from group A, type 14 Streptococcus pyogenes. Infect Immun (1975) 1.74
Active immunization of mice against Candida albicans. Proc Soc Exp Biol Med (1961) 1.51
Pathobiologic features of human candidiasis. A common deep mycosis of the brain, heart and kidney in the altered host. Am J Clin Pathol (1976) 1.49
Immunoprotective activity of ribosomes from Haemophilus influenzae. Infect Immun (1977) 1.44
Experience with Candida infections in the burn patient. Arch Surg (1972) 1.38
Immunogenicity of Ribosomal Preparations from Yeast Cells of Histoplasma capsulatum. Infect Immun (1974) 1.38
Experimental murine candidiasis: pathological and immune responses to cutaneous inoculation with Candida albicans. Infect Immun (1978) 1.25
Pseudomonas ribosomal vaccines: preparation, properties, and immunogenicity. Infect Immun (1978) 1.22
Adoptive transfer of immunity from mice immunized with ribosomes or live yeast cells of Histoplasma capsulatum. Infect Immun (1977) 1.18
ACQUIRED IMMUNITY TO CANDIDIASIS IN MICE. J Bacteriol (1963) 1.12
Immuno-stimulation by a ribosomal vaccine associated with a bacterial cell wall adjuvant in humans. Infect Immun (1978) 0.97
Evaluation of a ribosomal vaccine against pertussis. Infect Immun (1979) 0.93
Capsular serotypic specificity of the protection conferred on mice by Klebsiella pneumoniae ribosomal preparations. Infect Immun (1979) 0.93
Genetic relatedness of Candida albicans to asporogenous and ascosporogenous yeasts as reflected by nucleic acid homologies. Microbios (1974) 0.87
Immunization of mice with Trypanosoma cruzi polyribosomes. Infect Immun (1980) 0.82
Antibody formation in experimental immunizations with Candida albicans ribosomal fractions. Mycopathologia (1978) 0.80
Differentiation of 23-S ribosomal RNA cistrons from 16-S ribosomal RNA cistrons in Escherichia coli by the sequence complementarity test. Biochim Biophys Acta (1973) 0.80
Active immunity in experimental candidiasis in mice. Sabouraudia (1967) 0.80
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature (2000) 64.32
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. J Clin Oncol (1998) 8.40
Two populations of Ia-like molecules on a human B cell line. J Immunol (1980) 7.68
The genome of the natural genetic engineer Agrobacterium tumefaciens C58. Science (2001) 6.90
'Gene shaving' as a method for identifying distinct sets of genes with similar expression patterns. Genome Biol (2000) 5.29
IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma. Blood (1997) 4.97
Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med (1993) 4.91
Intragenic recombination leads to pilus antigenic variation in Neisseria gonorrhoeae. Nature (1985) 4.60
IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma. J Clin Oncol (1997) 4.32
Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat Med (1996) 4.15
The Lewy-body variant of Alzheimer's disease. Clinical and pathological findings. Br J Psychiatry (1993) 3.95
Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody. N Engl J Med (1982) 3.78
Studies of a human T lymphocyte antigen recognized by a monoclonal antibody. Proc Natl Acad Sci U S A (1981) 3.63
Obliquity-paced Pliocene West Antarctic ice sheet oscillations. Nature (2009) 3.42
Role of chromosomal rearrangement in N. gonorrhoeae pilus phase variation. Cell (1985) 3.30
Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors. N Engl J Med (1992) 2.73
Measuring client gains from staff-implemented programs. J Appl Behav Anal (1978) 2.72
Tacrine in Alzheimer's disease. Lancet (1991) 2.67
Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma. Nature (1993) 2.62
TAPA-1, the target of an antiproliferative antibody, defines a new family of transmembrane proteins. Mol Cell Biol (1990) 2.60
Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation. Nat Med (2000) 2.55
Antigenic variation of gonococcal pilus involves assembly of separated silent gene segments. Proc Natl Acad Sci U S A (1986) 2.53
Detection of T and B cell antigens hybridoma monoclonal antibodies: a biotin-avidin-horseradish peroxidase method. J Histochem Cytochem (1980) 2.52
Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma. Blood (1994) 2.48
Complete genome sequence of the genetically tractable hydrogenotrophic methanogen Methanococcus maripaludis. J Bacteriol (2004) 2.47
Prospective study to determine clinical relevance of detection of pneumococcal DNA in sera of children by PCR. J Clin Microbiol (1998) 2.42
The lymphochip: a specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes. Cold Spring Harb Symp Quant Biol (1999) 2.40
Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma: safety and efficacy of re-treatment. J Clin Oncol (2000) 2.38
Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma. Blood (2001) 2.35
A comparative study of visuospatial memory and learning in Alzheimer-type dementia and Parkinson's disease. Brain (1988) 2.32
The neural system that bridges reward and cognition in humans: an fMRI study. Proc Natl Acad Sci U S A (2002) 2.26
Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas. Proc Natl Acad Sci U S A (2000) 2.24
Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson's disease. Ann Neurol (1998) 2.21
Detection of Candida antigen in sera of patients with candidiasis by an enzyme-linked immunosorbent assay-inhibition technique. J Clin Microbiol (1979) 2.13
Optimization of quantitative real-time RT-PCR parameters for the study of lymphoid malignancies. Leukemia (2003) 2.12
Carbon monoxide re-breathing during low-flow anaesthesia in infants and children. Br J Anaesth (2010) 2.09
Rescue of immunoglobulin secretion from human neoplastic lymphoid cells by somatic cell hybridization. Proc Natl Acad Sci U S A (1978) 2.06
Hurthle cell carcinoma of the thyroid gland. A tumor of moderate malignancy. Cancer (1986) 2.04
Medical psychological observations during the Holocaust: escape into health. Adv Mind Body Med (1999) 2.02
Psychiatric phenomena in Alzheimer's disease. I: Disorders of thought content. Br J Psychiatry (1990) 2.01
In vitro binding of Candida albicans yeast cells to human fibronectin. Can J Microbiol (1984) 1.98
The monoclonality of human B-cell lymphomas. J Exp Med (1977) 1.97
Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma--long-term results of a clinical trial. Blood (1997) 1.96
A human thymus-leukemia antigen defined by hybridoma monoclonal antibodies. Proc Natl Acad Sci U S A (1979) 1.94
Lewy bodies and response to tacrine in Alzheimer's disease. Lancet (1994) 1.94
The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type. Br J Psychiatry (1989) 1.94
Clustering of extensive somatic mutations in the variable region of an immunoglobulin heavy chain gene from a human B cell lymphoma. Cell (1986) 1.92
Impaired lymphocyte function in untreated Hodgkin's disease. N Engl J Med (1974) 1.91
Therapy of B-cell lymphoma with anti-CD20 antibodies can result in the loss of CD20 antigen expression. Clin Cancer Res (1999) 1.91
A clinical trial of anti-idiotype therapy for B cell malignancy. Blood (1985) 1.91
Pathophysiologic mechanisms of acute graft-vs.-host disease. Biol Blood Marrow Transplant (1999) 1.90
Sustained increases in CD4 cell counts in asymptomatic human immunodeficiency virus type 1-seropositive patients treated with prednisolone for 1 year. J Infect Dis (1995) 1.88
Complications of intracranial pressure monitoring in fulminant hepatic failure. Lancet (1993) 1.87
Accuracy of clinical diagnosis of Alzheimer's disease. BMJ (1990) 1.84
Cognitive performance in tests sensitive to frontal lobe dysfunction in the elderly depressed. Psychol Med (1996) 1.84
Clonal evolution of a follicular lymphoma: evidence for antigen selection. Proc Natl Acad Sci U S A (1992) 1.82
The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice. Oncogene (1997) 1.81
Early medical use of cannabis. Nature (1993) 1.80
Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study. Blood (1982) 1.79
Biology of the human malignant lymphomas. IV. Functional characterization of ten diffuse histiocytic lymphoma cell lines. Cancer (1978) 1.77
Response of cutaneous T cell lymphoma to therapy with hybridoma monoclonal antibody. Lancet (1981) 1.76
Stroke volume variation as a predictor of fluid responsiveness in patients undergoing brain surgery. Anesth Analg (2001) 1.75
The inference of antigen selection on Ig genes. J Immunol (2000) 1.74
Mouse x human heterohybridomas as fusion partners with human B cell tumors. J Immunol Methods (1986) 1.73
Cytokeratins of normal epithelia and some neoplasms of the female genital tract. Lab Invest (1983) 1.70
Ectopic ACTH, prostatic oat cell carcinoma, and marked hypernatremia. Cancer (1977) 1.69
Immunologic phenotype in 30 patients with diffuse large-cell lymphoma. N Engl J Med (1980) 1.68
Computed tomography in the elderly. 2. Senile dementia: diagnosis and functional impairment. Br J Psychiatry (1980) 1.68
Monocyte dysfunction in patients with Gaucher disease: evidence for interference of glucocerebroside with superoxide generation. Blood (1994) 1.68
Microstimulation-induced inhibition of neuronal firing in human globus pallidus. J Neurophysiol (2000) 1.67
TAPA-1, the target of an antiproliferative antibody, is associated on the cell surface with the Leu-13 antigen. J Immunol (1990) 1.65
Human T lymphocytes and monocytes bear the same Leu-3(T4) antigen. J Immunol (1986) 1.65
Coupled temporal memories in Parkinson's disease: a dopamine-related dysfunction. J Cogn Neurosci (1998) 1.64
A human X-linked antigen defined by a monoclonal antibody. Somatic Cell Genet (1980) 1.64
Computerised tomography in Alzheimer's disease. Methods of scan analysis, comparison with normal controls, and clinical/radiological associations. Br J Psychiatry (1991) 1.63
Recombinant activated factor VII for adjunctive hemorrhage control in trauma. J Trauma (2001) 1.63
Use of family specific leader region primers for PCR amplification of the human heavy chain variable region gene repertoire. Mol Immunol (1992) 1.61
Apolipoprotein E: non-cognitive symptoms and cognitive decline in late onset Alzheimer's disease. J Neurol Neurosurg Psychiatry (1996) 1.60
Age associated memory impairment. BMJ (1992) 1.54
In vivo effects of murine hybridoma monoclonal antibody in a patient with T-cell leukemia. Blood (1981) 1.52
Developmental regulation of the cysteine-rich outer-membrane proteins of murine Chlamydia trachomatis. J Gen Microbiol (1988) 1.52
Multicenter trial of octreotide in patients with refractory acquired immunodeficiency syndrome-associated diarrhea. Gastroenterology (1995) 1.51
Exogenous immunoglobulin and the macrophage origin of Reed-Sternberg cells in Hodgkin's disease. N Engl J Med (1978) 1.51
Motivation, reward, and Parkinson's disease: influence of dopatherapy. Neuropsychologia (2002) 1.51
Biotyping of Candida albicans: results of an international collaborative survey. J Clin Microbiol (1989) 1.50
Bioassay of three strains of Bacillus sphaericus on field-collected mosquito larvae. J Invertebr Pathol (1977) 1.50
Spontaneous release of the Leu-2 (T8) molecule from human T cells. J Exp Med (1983) 1.48
The covalent binding of daunomycin and adriamycin to antibodies, with retention of both drug and antibody activities. Cancer Res (1975) 1.48
Yttrium-90-labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphoma. Clin Cancer Res (1996) 1.47
On certain peculiar diseases of old age. Hist Psychiatry (1991) 1.46
Preliminary observations on the effect of human leukocyte interferon in non-Hodgkin's lymphoma. N Engl J Med (1978) 1.44
Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody. J Clin Oncol (1989) 1.43
Monoclonal anti-idiotype antibodies against the murine B cell lymphoma 38C13: characterization and use as probes for the biology of the tumor in vivo and in vitro. Hybridoma (1985) 1.43
Evaluation of a new system for the rapid identification of clinically important yeasts. J Clin Microbiol (1976) 1.42
The role of dorsolateral prefrontal cortex in the preparation of forthcoming actions: an fMRI study. Cereb Cortex (2001) 1.42
[Right heart failure caused by thiamine deficiency (cardiac beriberi)]. Presse Med (2000) 1.41
Choline in Alzheimers disease. Lancet (1978) 1.41
Executive functions and updating of the contents of working memory in unipolar depression. J Psychiatr Res (2004) 1.41
In vitro adherence of Candida albicans to human corneocytes. Inhibition by chitin-soluble extract. Acta Derm Venereol (1988) 1.40